PLX-R18 (Avoplacel), a Placental Expanded Mesenchymal-like Stromal Cell Therapy Shows Favorable Safety and Appears to Improve Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation (HCT)
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10447-10448
10.1182/blood-2022-169266